Xiaoping Su

40.5k citations
219 papers · 31.2k · 22 hit papers · h-index 72

Impact in

    • Cancer Genomics and Diagnostics
    • Cancer-related molecular mechanisms research
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Cancer Genomics and Diagnostics 33
    • Cancer-related molecular mechanisms research 12
    • Cancer Immunotherapy and Biomarkers 21

Xiaoping Su

209 papers receiving 30.7k citations

Xiaoping Su's Hit Papers

Comprehensive molecular characterization of mitochondrial genomes in human cancers 2020 · 319 citations
3190+3+7Years since publication5001k1.5k2k

Peers

Xiaoping Su
Comparison fields: 5 of 154
  • Cancer Research 6.9k
  • Oncology 4.4k
  • Hepatology 1.3k
  • Hematology 1.9k
  • Genetics 1.2k
Replace Hiroko Tanaka with:
Hiroko Tanaka Japan
Birgit Burkhardt Germany
Yuichi Shiraishi Japan
Fumie Hosoda Japan
Sandrine Boyault France
Sam Behjati United Kingdom
Wolfram Klapper Germany
Karen Smith‐McCune United States
Genta Nagae Japan
Ignacio Varela Spain
Xiaoping Su relative to Hiroko Tanaka Japan Hiroko Tanaka's profile →
Citations per field
00.5×1.6×
Hiroko Tanaka · 1×
Citations per year

Countries citing papers authored by Xiaoping Su

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Su more than expected).

Fields of papers citing papers by Xiaoping Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Su. The network helps show where Xiaoping Su may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoping Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoping Su Line = papers co-authored together Xiaoping Su links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 219 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The repertoire of mutational signatures in human cancer
Hit paper breakdown →
20202401
2
Pan-cancer analysis of whole genomes
Hit paper breakdown →
20202169
3
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Hit paper breakdown →
20171989
4
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
Hit paper breakdown →
20171951
5
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Hit paper breakdown →
20071488
6
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Hit paper breakdown →
20091179
7
PD-L1 Expression in Triple-Negative Breast Cancer
Hit paper breakdown →
20141158
8
Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression
Hit paper breakdown →
2017966
9
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Hit paper breakdown →
2009794
10
The evolutionary history of 2,658 cancers
Hit paper breakdown →
2020730
11 2005680
12
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Hit paper breakdown →
2015678
13
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Hit paper breakdown →
2008660
14
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
Hit paper breakdown →
2012582
15
Patterns of somatic structural variation in human cancer genomes
Hit paper breakdown →
2020564
16 2006525
17
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Hit paper breakdown →
2020489
18
JAK mutations in high-risk childhood acute lymphoblastic leukemia
Hit paper breakdown →
2009470
19
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Hit paper breakdown →
2020428
20
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
Hit paper breakdown →
2018359

About Xiaoping Su

Xiaoping Su is a scholar working on Cancer Research, Oncology, Hematology, Molecular Biology and Immunology, having authored 219 papers that have together received 31.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (33 papers), Acute Myeloid Leukemia Research (22 papers), Cancer Immunotherapy and Biomarkers (21 papers), Acute Lymphoblastic Leukemia research (18 papers), Renal cell carcinoma treatment (17 papers), Immunotherapy and Immune Responses (13 papers), Cancer-related molecular mechanisms research (12 papers) and Chromatin Remodeling and Cancer (9 papers). The work is most often cited by research in Cancer Research (6.9k citations), Oncology (4.4k citations), Hepatology (1.3k citations), Hematology (1.9k citations) and Genetics (1.2k citations). Xiaoping Su has collaborated with scholars based in United States, China and France. Frequent co-authors include James R. Downing, Charles Grenfell Mullighan, Christopher B. Miller, Jing Ma, Sheila A. Shurtleff, Ching‐Hon Pui, Elaine Coustan‐Smith, Xuetao Cao, Letha A. Phillips and James Dalton. Their work appears in journals such as Blood, Nature Communications, Nature, Cancer Cell and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact